Quest Diagnostics Inc (LTS:0KSX)
$ 152.97 0 (0%) Market Cap: 17.12 Bil Enterprise Value: 23.44 Bil PE Ratio: 20.57 PB Ratio: 2.52 GF Score: 83/100

Quest Diagnostics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 09, 2021 / 01:30PM GMT
Release Date Price: $155.92
Rivka Regina Goldwasser
Morgan Stanley, Research Division - MD

Good morning, everybody. I'm Ricky Goldwasser, Morgan Stanley's Healthcare Services' analyst, and I'm pleased to welcome you all to Morgan Stanley Global Healthcare Conference.

On with me this morning are Steve Rusckowski, Quest Diagnostics' CEO; Jim Davis, EVP of General Diagnostics; and Shawn Bevec, who is Head of IR. Steve, Jim and Shawn will join us today and share some of their insights. Before we get started, I would like to note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. It's not for the members of the press. And if you are a member of the press, please disconnect and reach out separately. And for any important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures.

And with that, thank you again for joining us. And Steve, you guys raised your guidance earlier this morning to reflect the accelerated demand for COVID

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot